|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28,800 KRW | +0.88% |
|
+0.70% | +3.78% |
| 2023 | Daihan Pharmaceutical Co.,Ltd.(KOSDAQ:A023910) dropped from S&P Global BMI Index | CI |
| 2023 | Daihan Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:A023910) announces a share repurchase program. Under the program, the company will repurchase up to 120,000 shares. The purpose of the program is stock price stability and shareholder value enhancement.
The program will expire on December 28, 2022. As of September 28, 2022, the company had 0 treasury stock holdings in acquisition within the scope of allotment and through other acquisition, respectively.
| 1st Jan change | Capi. | |
|---|---|---|
| +3.78% | 125M | |
| +21.59% | 44.15B | |
| +23.03% | 23.02B | |
| +18.22% | 15.33B | |
| +12.26% | 13.74B | |
| +52.55% | 12.16B | |
| -10.02% | 6.84B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +12.92% | 5.66B |
DAIHAN PHARMACEUTICAL CO.,LTD. 